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0 1996 by The American Society of Hematology. structure containing extracellular epidermal growth factor homology domains, Ig-like loops, and fibronectin type 111 homology domains. Tie is prominently expressed in endothelial cells of a variety of murine and human tissues including differentiating angioblasts and vascular endothelial cells of embryos.Is It has been suggested that Tie is expressed in primitive hematopoietic cells, because it is found in the developing blood islands of mouse embryos" as well as in murine bone marrow (BM) stem cell fractions.'" We have studied here the expression pattern of Tie in human hematopoietic cells, with a particular emphasis on the different subsets of CD34' cells and on myeloid, erythroid, and megakaryocytic cells differentiating from CD34' cells.
MATERIALS AND METHODS

Cells. The HEL
(erythro/megakaryoblastic leukemia), KG-la (myeloid leukemia), and MOLT-4 (T-lymphoblastic leukemia) cell lines were obtained from the American Type Culture Collection (Rockville, MD). The EAehy926 hybrid endothelial cells were a kind gift from Dr C.J. Edgell (University of North Carolina, Chapel Hill, NC). Normal peripheral blood cells, BM cells, umbilical cord blood (UCB), and leukemic samples were obtained in accordance with the institutional guidelines of the Committee on Human Investigation. Mononuclear cells were isolated using discontinuous Ficoll/ Hypaque (Pharmacia [Uppsala. Sweden] or Seromed [Berlin, GermanyJ) density gradient centrifugation. Platelet-enriched plasmas were obtained from normal donors.
I.solatiot1 of CD34' UCB und BM cells. CD34' cells were isolated from BM or UCB mononuclear cells by AIS panning (Applied Immune Science, Santa Clara, CA) as previously described," using the MACS CD34 Progenitor Cell Isolation kit (Miltenyi Biotech. Bergisch Gladbach, Germany) or Dynal kit (Dynabeads M450 CD34; Dynal, Compikgne, France) according to the instructions of the manufacturer. The purity of the CD34' populations ranged from 87% to 98%.
Liquid cultures. CD34-cells were plated at I X IOJ to 4 X lo( ceIls/mL in 96-well tissue-culture plates (Nunc [ rum albumin, 1.7 X lo-' mol/L 2-mercaptoethanol, 1.7 U/mL of recombinant human interleukin-3 [rhuIL-3], IO U/mL of rhuIL-6, 3 U/mL of rhu granulocyte colony-stimulating factor [rhuG-CSF; kind gifts from Genetics Institute, Cambridge, MA), 6 ng/mL of rhu stem cell factor [rhuSCF a kind gift from S. Gillis, Immunex, Seattle, WA], and 1 U/mL of rhu erythropoietin [rhuEpo; a kind gift from Amgen Biologicals, Thousand Oaks, CA]). StemGEM* medium supplemented with thrombopoietin (TPO) and plasma was used to study megakaryocytic differentiation of UCB CD34' cells in the experiment shown in Fig 6. TPO used in this experiment was kindly provided by Zymogenetics (Seattle, WA). Cells were incubated at 37°C in a humidified atmosphere containing 5% CO2 and were harvested after defined periods for in situ hybridization (ISH) or for analysis of phenotype. Cell proliferation was estimated by counting cell numbers in a Malassez chamber at each time point. For the megakaryocytic differentiation of BM CD34' cells in the experiment shown in Fig 8, BM CD34' cells were kept for 9 days at a concentration of I X 10' cells per 500 pL in serum-free liquid medium in 24-well plates, as previously published.IR The medium contained 1.5% bovine serum albumin (Cohn's fraction V; Sigma, St Louis, MO), sonicated lipids, and iron-saturated human transfemn and was supplemented with the supernatant (IO pllmL) of a COS cell line transfected with human TPO (Mpl-ligand) cDNA (generous gift from J.L. Villeval and F. Wendling, Institut Gustave Rousy, Villejuif, France). Cultures were analyzed on day 9 of differentiation.
For the experiment shown in Fig 7, the following culture conditions were used instead. Isolated CD34' UCB cells were cultured in 24-well plates (1 X IO4 cells in 1 mL/well; Costar, Cambridge, MA) in RPM1 1640 supplemented with L-glutamine (2.5 mmol/L), penicillin (125 IU/mL), streptomycin (125 pg/mL), and pooled cord blood plasma ( I 0%). For growth induction, the recombinant human cytokines rhu granulocyte-macrophage CSF (GM-CSF; 100 ng/mL; Sandoz, Basel, Switzerland), rhuSCF (20 ng/mL; Amgen), and rh tumor necrosis factor a (TNFcr; 50 UlmL; Bender, Vienna, Austria) were added. After 8 days in culture, cells were harvested, counted, and
Immunojluorescence staining and analysis. For immunofluorescent labeling, about 50 pL of cells ( IO6 to 107/mL) were incubated for 15 to 30 minutes at 4% with 5 to 20 pL of the appropriately diluted antibody solutions. For direct labeling, a one-step procedure was performed using one or more fluorochrome-conjugated antibodies at the same time. Antibody conjugates included the following:
, and anti-myeloperoxidase (anti-MP0)-FITC or anti-MPO-PE (An der Grub, Kaumberg, Austria; available in the USA from Caltag). A two-step procedure was performed for indirect labeling, using first the unconjugated antibody and then the antimouse antibody conjugated with a fluorochrome. In some cases, indirect labeling was followed by direct labeling. ISH. The complete procedure has been detailed in a previous report." Briefly, antisense and sense Tie RNA probes" were synthesized using the Riboprobe II Core System (Promega, Madison, WI) and [35S]-uridine triphosphate. The transfemn receptor probe (a generous gift of Dr C. Schneider, EMBL, Heidelberg, Germany) was used as a positive control. The specific activity of the labeled probe was about 1.3 X IO9 cprnfpg. A total of 1 X IO6 cpm were aliquoted on each slide. Nonspecific binding was prevented by use of Escherichia coli tRNA (500 pg/mL). After 12 days of exposure, the slides were developed and stained with Giemsa (Merck, Darmstadt, Germany). In the negative controls, the majority of cells contained no more than 2 grains per cell. Each cell on the reaction slides containing more than 6 grains was scored as positive. The number of grains per cell was counted using Leitz microscope (E. Leitz Inc, Wetzlar, Germany) and SAMBA image analyser (Alcatel TITN Answare, Meylan, France) with "Autoradiography" software from Alcatel. The number of grains per cell was corrected by substracting for the background level, and the results were grouped in categories of 3 grains per cell (0 to 3, 4 to 6, and so on).
Immunoprecipitation and Western blotting. LEII GD 14-2 cells transfected with the full-length Tie cDNA in pGD retroviral vecto?' and nontransfected control LEII cells were lysed in NP-40 lysis buffer (150 mmol/L NaCI, 50 mmol/L Tris-HCI, 1% NP-40 [pH 8.01). The lysates were centrifuged at 15,000 rpm in an Eppendorf (Hamburg, Germany) centrifuge for 30 minutes, and the supernatants were used for immunoprecipitation of Tie with different MoAbs (IO &lysate) or, as a positive control, with the polyclonal rabbit antiTie antiserum MIL5 The immunoprecipitates were analyzed in 6% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and were blotted to nitrocellulose, and Tie was detected with anti-GST-Tie MoAb 4B2 directed against a bacterially expressed glutathione-Stransferase fusion protein containing Tie amino acid residues 162-350 (Kukk et al, manuscript submitted). For analysis of Tie immunoprecipitates using gel electrophoresis and autoradiography, the LEII GD14-2 cells were metabolically labeled with 100 pCi/mL [%l-methionine (Amersham) for 4 hours and used for immunoprecipitation as above.
RESULTS
Detection of Tie protein by MoAbs.
MoAbs against the extracellular domain of Tie were used in the detection of the Tie protein from LEII cells transfected with the Tie expression vector. Immunoprecipitation of Tie was followed by gel electrophoresis and Western immunoblotting using antiTie MoAb 4B2. Rabbit antiserum MI1 against the carboxyl terminal 15 amino acid peptide of Tie was used as a positive control in the immun~precipitation.~~~~ The results showed that MoAbs against four distinct epitopes of the Tie extracellular domain specifically immunoprecipitate Tie from the transfected cells (Fig 1A) but did not recognize Tie in Westem blots (data not shown), presumably because the antigen is denatured in the latter procedure. A pool of four MoAbs against different Tie epitopes gave the strongest signals and resulted in quantitative immunoprecipitation of the Tie protein from the lysates of cells labeled with radioactive methionine (Fig 1B) .
Detection of cell surface Tie antigen. HEL cells, which coexpress erythroid and megakaryocytic markers as well as Tie mRNA and protein," were used to calibrate flow cytometric analyses using anti-Tie MoAbs. MOLT4 cells were (Fig 2) .' Normal peripheral blood mononu--clear cells were uniformly Tieconditions (data not shown).
. . under the same staining (Fig 2) .
On average, 6 4 % 5 9.2% (minimum, 55%; maximum, 79%; 4 samples; see Fig 3A) of gated UCB CD34' cells were Tie'. Slightly lower values (30% to 60%) were obtained for BM CD34' cells.
Further analysis of the purified UCB CD34' cells for hematopoietic markers discriminating early progenitors showed that most of the CD34' cells expressing low levels of CD38 were Tie' (Fig 3B) . However, Tie' cells also appeared in the other fraction expressing higher levels of CD38. The majority of the CD34' cells expressing high levels of c-Kit were also Tie', whereas those expressing low levels of c-Kit were either Tie' or Tie- (Fig 3C) . On the other hand, the CD34'Tie-cells expressed intermediate levels of CD38 (Fig 3B) . In BM, there was an inverse correlation between expression of Tie and the stage of maturation of CD34' cells. Indeed, among subsets of BM CD34' cells, almost the entire CD34'CD38'" cell population (about 30% of the CD34+ cells; see Fig 4A and B) and the CD34+ Thy-1' population (15% of the CD34+ cells; see Fig 4C) were clearly labeled by the anti-Tie antibodies. In contrast, no more than 30% to SO% of the residual CD34' cells (CD38+ or Thy-l-) were Tie+. Similar results were also observed with the rare CD34+HLA-DR-cells (4% of the BM CD34+ cells; see Fig 4D) . These results show that Tie is expressed more consistently in phenotypically immature cells than in the more mature CD34+ cells.
Regulation of Tie mRNA and protein during differentiation
of CD34+ cells in culture. In ISH analysis, the majority of BM CD34+ cells expressed Tie mRNA (Fig SA) . Negative controls using a sense Tie probe remained unlabeled in all tested conditions. Tie expression decreased to a low level in medium containing IL-3, L-6, SCF, G-CSF, and Epo during 14 days of proliferation, resulting in a nearly 100-fold expansion of the cell population (Fig SB) . Similar results were obtained for UCB CD34+ cells (data not shown). Positive controls obtained with cells hybridized with a transferrin receptor probe showed strong labeling (30 to 60 grains per cell) during differentiation (data not shown).
A decrease of Tie protein expression paralleled a decrease of CD34 antigen expression during a 10-day culture of the UCB cells (Table 1) . During this time period in appropriate 
media, CD34' cells differentiate into myeloid cells (CD33+CD4Shi) or erythroid cells (glycophorin A'CD45'").
Tie expression was observed on only about 60% of the remaining CD34' cells, which also expressed intermediate levels of CD45 (Fig 6A through C) . Because glycophorin A is expressed on erythroid cells having a low level of CD45, this result suggests that Tie is not expressed on differentiated erythroid cells. In these culture conditions, cells from the megakaryocytic lineage (CD42b') are difficult to detect (<1.5%). In StemGEM* medium supplemented with TPO, which promotes megakaryocytic differentiation of UCB CD34' cells, an increased proportion of CD34-cells expressed Tie (Fig 6D) . In two different experiments, about 90% and 95% and 50% and 44% of CD42b+ cells were Tie' on days 7 and 10, respectively, in such cultures (Fig 6E and  F) . Most of the CD42b+ cells expressed intermediate levels of CD45 and had lost CD34 (data not shown). Tie was also decreased in UCB CD34' cells during 8 days of culture in medium containing SCF, GM-CSF, and TNFa (Fig 7) . In these cultures, cells positive for the myeloid marker MP0 were negative for Tie.
About 60% of the purified BM CD34+CD41+ cells were positive for Tie (Fig 8A) , but cultured megakaryocytes growing in medium containing supernatant of the COS cell line transfected with human TPO cDNA lost expression or were only slightly labeled (about 15%; see Fig 8B) . Platelets puri-BATARD ET AL fied from plasma were comparatively weakly stained ( Fig  8C) .
DISCUSSION
The pattern of Tie receptor TK mRNA and protein expression in tissues and tumor cell lines suggests that this gene is involved in angiogenesis and hematopoiesis and in the megakaryocytic differentiation pathway." Our present studies show that Tie mRNA and protein are expressed on a large fraction of UCB and BM CD34' cells. Notably, Tie was expressed on the UCB and BM CD34+CD38'", BM CD34+HLA-DR-, and CD34'Thy-I + subpopulations, which are enriched in immature hematopoietic progenitors.'5~1' Also, a significant fraction of the CD34'c-Kit'" subpopulation, presumed to contain early progenitors,'*~'' was Tie'. Although our results suggest that most immature hematopoietic progenitors express Tie, further studies of the CD34TD38-Tie' and CD34'CDX-Tie-cells in culture will be required to assay their functional properties. This experiment will be even more informative when the Tie ligand is available.
Because Tie is mainly detected on endothelial cells that also express CD34, we excluded the possibility that the Tie' CD34+ cells were contaminating endothelial cells by using the hematopoietic cell-specific CD45 as a marker. Thus, our results suggest that Tie is expressed more consistently on immature cells than on more mature CD34' cells. Similarly, the ISH analyses showed Tie mRNA expression in the CD34' cells. Our results are consistent with those of Iwama et al,I6 who found Tie (and Tek) RNA expression in the mouse BM Lin-c-Kit+Sca-1 ' fraction. In fact, we have obtained similar results by reverse transcription-polymerase chain reaction amplification of RNA from defined mouse hematopoietic cell colonies isolated by micromanipulation (Kukk et al, manuscript submitted).
The parallel disappearance of Tie and CD34 antigens during hematopoietic cell differentiation in culture was consistently observed. In addition, Tie was expressed on 60% o f BM CD34+CD41' cells but on only 15% of the more differentiated megakaryocytic progeny derived from BM CD34 + cells. About 90% and about 40% to 50% of the megakaryocytic cells obtained by allowing the UCB CD34' cells to differentiate in vitro in the presence of TPO expressed Tie on days 7 and 10, respectively, of culture. The difference between the values for the BM and UCB megakaryocytic The ligands of all three receptors have been studied for their effects on hematopoietic cell proliferation and differentiation.
Tie is present on virtually all vascular endothelial cells as shown by mRNA ISH analysis of developing mouse embryos, healing wounds, and human tumor t i s s~e . '~,~~ Interestingly, endothelial cells and hematopoietic stem cells are believed to derive from a common precursor cell, the so-called hemangioblast. A high-affinity receptor for vascular endothelial growth factor is expressed in hemangioblasts and also in certain hematopoietic and leukemia cells. This receptor, variously called VEGFR-;?/Kdr/Flk-1 (kinase insert domaincontaining receptor/fetal liver kina~e-l~'.~') was cloned from primitive hematopoietic cells from mouse liver?* VEGFR-2 occurs mainly in vascular endothelial cells, and only endothelial cells have been reported to proliferate in response to VEGF?4 Targeted homozygous null mutations of VEGFR-2 indicate that it is required for the formation of blood islands and, later, blood vessels and for hematopoiesi~?~ whereas the related VEGFR-l/Flt-1 plays an essential role in endothelial organization during vascular development. 44 Neither Tie nor Tek alone is required for hematopoietic stem cell function per se, because disruption of either gene locus by targeted mutagenesis does not abolish hematopoiesis.45*46 However, Tek-deficient mouse embryos died very early, soon after the gene should have been expressed. The number of endothelial cells was dramatically decreased, the heart was underdeveloped, and severe hemorrhaging was detected.'" Tie-deficient mice died of hemorrhaging later during devel~pment."~.~~ Currently, it is not known whether hematopoietic cells such as megakaryocytes in these mice are also affected by Tie gene disruption or whether there is hematopoiesis in Tie-/-Tek-/-double-knockout embryos. Further studies on Tie+ cell subpopulations and on the effects of the Tie ligand should help us to better understand and potentially control human hematopoietic stem cells for transplantation or applications of gene therapy.
